Neogen Chemicals Limited
NSE: NEOGEN · Specialty Chemicals
Snapshot
Unlock Neogen Chemicals Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Neogen Chemicals Limited is a manufacturer of specialty chemicals, specialising in bromine-based compounds, lithium salts, and Grignard reagents. The company serves a diverse range of industries including pharmaceuticals, agrochemicals, electronics, and engineering, while also providing custom synthesis and manufacturing services.
Business Model
The company generates revenue through the production and sale of a wide portfolio of specialty chemical intermediates and by offering custom synthesis services to global clients. It leverages its expertise in bromine chemistry to supply critical components to various industrial sectors across domestic and international markets.
- Export reach:28 countries
- Incorporation year:1989
Growth Outlook
Growth is driven by the expansion of custom synthesis and manufacturing services alongside the increasing demand for specialty bromine and lithium-based chemicals in high-growth sectors like electronics and pharmaceuticals. The company continues to leverage its technical capabilities to cater to complex chemical requirements globally.
Key Risks
- Raw Material Price Volatility. Fluctuations in the prices of bromine and lithium, which are key raw materials, can significantly impact profit margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate high capital expenditure for compliance.
- Geopolitical and Export Risks. As the company exports to 28 countries, it remains exposed to currency fluctuations, trade barriers, and geopolitical instability in international markets.
- Customer Concentration. Dependence on specific industries like pharmaceuticals and agrochemicals may lead to revenue volatility if these sectors experience a downturn.
Start your research today
Unlock AI insights, financials, peers and live data on Neogen Chemicals Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹926 Cr
TTM · consolidated
NET PROFIT
₹36 Cr
TTM · consolidated
EPS
₹13.29
TTM · consolidated
RETURN ON EQUITY
4.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
9.7%
TTM · consolidated
P/E
160.9x
Q1 FY27 · consolidated
EV/EBITDA
44.1x
Q1 FY27 · consolidated
EBITDA MARGIN
17.6%
TTM · consolidated
NET PROFIT MARGIN
6.8%
Q1 FY27 · consolidated
DEBT TO EQUITY
1.6x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Neogen Chemicals LimitedNEOGEN | ₹5,854 Cr | 160.87 | 44.08 | 18.0% | 17.6% | 4.4% | 9.7% | +44.9% |
Archean Chemical Industries LimitedACI | ₹6,225 Cr | 63.90 | 26.36 | -0.4% | 22.6% | 5.0% | 7.2% | -26.7% |
Fineotex Chemical LimitedFCL | ₹5,998 Cr | 15.52 | 29.45 | 91.4% | 20.0% | 18.4% | 22.0% | -78.3% |
Epigral LimitedEPIGRAL | ₹5,262 Cr | 19.42 | 9.80 | 4.8% | 22.6% | 13.1% | 15.5% | -31.2% |
Yasho IndustriesYASHO | ₹4,985 Cr | 86.43 | 29.85 | 35.3% | 19.7% | 13.4% | 16.5% | +121.7% |
Laxmi Organic Industries LimitedLXCHEM | ₹4,769 Cr | 37.89 | 19.57 | 5.5% | 8.6% | 6.5% | 8.3% | -19.6% |
As of Q1 FY27
Financials
Neogen Chemicals Limited
NSE: NEOGEN · Specialty Chemicals
Snapshot
Unlock Neogen Chemicals Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Neogen Chemicals Limited is a manufacturer of specialty chemicals, specialising in bromine-based compounds, lithium salts, and Grignard reagents. The company serves a diverse range of industries including pharmaceuticals, agrochemicals, electronics, and engineering, while also providing custom synthesis and manufacturing services.
Business Model
The company generates revenue through the production and sale of a wide portfolio of specialty chemical intermediates and by offering custom synthesis services to global clients. It leverages its expertise in bromine chemistry to supply critical components to various industrial sectors across domestic and international markets.
- Export reach:28 countries
- Incorporation year:1989
Growth Outlook
Growth is driven by the expansion of custom synthesis and manufacturing services alongside the increasing demand for specialty bromine and lithium-based chemicals in high-growth sectors like electronics and pharmaceuticals. The company continues to leverage its technical capabilities to cater to complex chemical requirements globally.
Key Risks
- Raw Material Price Volatility. Fluctuations in the prices of bromine and lithium, which are key raw materials, can significantly impact profit margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate high capital expenditure for compliance.
- Geopolitical and Export Risks. As the company exports to 28 countries, it remains exposed to currency fluctuations, trade barriers, and geopolitical instability in international markets.
- Customer Concentration. Dependence on specific industries like pharmaceuticals and agrochemicals may lead to revenue volatility if these sectors experience a downturn.
Start your research today
Unlock AI insights, financials, peers and live data on Neogen Chemicals Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹926 Cr
TTM · consolidated
NET PROFIT
₹36 Cr
TTM · consolidated
EPS
₹13.29
TTM · consolidated
RETURN ON EQUITY
4.4%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
9.7%
TTM · consolidated
P/E
160.9x
Q1 FY27 · consolidated
EV/EBITDA
44.1x
Q1 FY27 · consolidated
EBITDA MARGIN
17.6%
TTM · consolidated
NET PROFIT MARGIN
6.8%
Q1 FY27 · consolidated
DEBT TO EQUITY
1.6x
Q1 FY27 · consolidated
Peers · Specialty Chemicals
As of Q1 FY27